5Suppliers
0Customers
3Debt Items
0Related Chains
ABVC BioPharma, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| BIOFIRST-CORPORATION |
BIOFIRST-CORPORATION |
90%
|
Definitive License Agreement between BioFirst Corporationand ForSeeCon Eye Corporation |
| BIOLITE-INC |
BIOLITE-INC |
90%
|
Definitive License Agreement between Biolite, Inc. and OncoX BioPharma, Inc. |
| FORSEECON-EYE-CORPORATION |
FORSEECON-EYE-CORPORATION |
90%
|
Definitive License Agreement between the Company and ForSeeCon Eye Corporation |
| ONCOX-BIOPHARMA-INC |
ONCOX-BIOPHARMA-INC |
90%
|
Definitive License Agreement between the Company and OncoX BioPharma, Inc. |
| RGENE |
RGENE |
90%
|
Definitive License Agreement between Rgene and OncoX BioPharma, Inc. |
ABVC BioPharma, Inc. Customers
No clients on recordNo downstream customers found in our database for ABVC BioPharma, Inc..
ABVC BioPharma, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| ABVC-DEBT-7446 |
Warrants outstanding: 500000 |
90%
|
xbrl warrant detail from xbrl 2025-12-31. |
| ABVC-DEBT-7447 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2025-12-31. |
| ABVC-DEBT |
Debt stack $3.5M |
90%
|
Market cache reports total debt of $3.5M. |
ABVC BioPharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ABVC BioPharma, Inc..
ABVC BioPharma, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| ABVC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC |
VANGUARD CAPITAL MANAGEMENT LLC |
90%
|
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 15 tracked holders. |
ABVC BioPharma, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
